Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer
Carey K. Anders(Duke University), William C. Zamboni(AstraZeneca (United Kingdom)), David B. Darr(University of North Carolina at Chapel Hill), Ryan Bash(University of North Carolina at Chapel Hill), C. Ryan Miller(University of North Carolina at Chapel Hill), Sumit Rawal(University of North Carolina at Chapel Hill), Tal Kafri(University of North Carolina at Chapel Hill), Lisa A. Carey(University of North Carolina at Chapel Hill), Allison N. Schorzman(University of North Carolina at Chapel Hill), Charles M. Perou(University of North Carolina at Chapel Hill), Allison M. Deal(Memorial Sloan Kettering Cancer Center), Olga Karginova(University of Illinois Chicago), Bárbara Adamo(Hospital Clínic de Barcelona), Charlene Santos(University of North Carolina at Chapel Hill), Norman E. Sharpless(University of North Carolina at Chapel Hill)
Cited by 89
Related Papers
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
|Clinical Cancer Research|2004|2.7k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k